Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: dermal

Currently viewing:

Administrative data

Endpoint:
acute toxicity: dermal
Type of information:
experimental study
Remarks:
Read across data
Adequacy of study:
supporting study
Reliability:
4 (not assignable)
Rationale for reliability incl. deficiencies:
secondary literature
Justification for type of information:
Data is taken from a secondary source

Data source

Reference
Reference Type:
other: Secondar source
Title:
SIDS Initial Assessment Report For SIAM 17
Author:
OECD-SIAM
Year:
2003
Bibliographic source:
OECD SIDS, SIAM, 2003

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 402 (Acute Dermal Toxicity)
Version / remarks:
1966
Principles of method if other than guideline:
The study appears to be similar to OECD TG 402, but the level of detail in the report is such that this cannot be confirmed.
GLP compliance:
not specified
Test type:
standard acute method

Test material

Constituent 1
Chemical structure
Reference substance name:
N-(3-(trimethoxysilyl)propyl)ethylenediamine
EC Number:
217-164-6
EC Name:
N-(3-(trimethoxysilyl)propyl)ethylenediamine
Cas Number:
1760-24-3
Molecular formula:
C8H22N2O3Si
IUPAC Name:
(2-Aminoethyl)(3-(trimethoxysilyl)propyl)amine
Test material form:
liquid
Specific details on test material used for the study:
Not specified

Test animals

Species:
rabbit
Strain:
New Zealand White
Sex:
male
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Rationale for alternative/additional species to rat (if applicable) No data Avaiable
- Source: Epona Associates, LLC
- Females (if applicable) nulliparous and non-pregnant: [yes/no] No data Avaiable
- Rationale for use of males (if applicable) No data Avaiable
- Age at study initiation: three to five months
- Weight at study initiation: No data Avaiable
- Fasting period before study: No data Avaiable
- Housing: No data Avaiable
- Historical data: No data Avaiable
- Diet (e.g. ad libitum): No data Avaiable
- Water (e.g. ad libitum): No data Avaiable
- Acclimation period: No data Avaiable
- Microbiological status when known No data Avaiable
- Method of randomisation in assigning animals to test and control groups No data Avaiable

ENVIRONMENTAL CONDITIONS
- Temperature (°C): No data Avaiable
- Humidity (%): No data Avaiable
- Air changes (per hr): No data Avaiable
- Photoperiod (hrs dark / hrs light): No data Avaiable

IN-LIFE DATES: From: To:

Administration / exposure

Type of coverage:
occlusive
Vehicle:
unchanged (no vehicle)
Details on dermal exposure:
TEST SITE
- Area of exposure:
- % coverage:
- Type of wrap if used: polyethylene sheeting

REMOVAL OF TEST SUBSTANCE
- Washing (if done): done
- Time after start of exposure: 24 hrs

TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 16.0 (2 animals) or 8.0 (4 animals) ml/kg
- Concentration (if solution): No data avaiable
- Constant volume or concentration used: yes/no No data avaiable
- For solids, paste formed: yes/no

VEHICLE
- Amount(s) applied (volume or weight with unit): No data avaiable
- Concentration (if solution): No data avaiable
- Lot/batch no. (if required): No data avaiable
- Purity:No data avaiable
Duration of exposure:
24 hours
Doses:

16 and 8 ml/kg bw
No. of animals per sex per dose:
8 ml/kg: 4
16 ml/kg: 2
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days (or other?) 14 days
- Frequency of observations and weighing: No data avaiable
- Necropsy of survivors performed: yes
- Clinical signs including body weight No data avaiable
- Other examinations performed: clinical signs, body weight,organ weights, histopathology, other:
Statistics:

average method based

Results and discussion

Effect levels
Sex:
male
Dose descriptor:
LD50
Effect level:
16 mL/kg bw
Based on:
test mat.
95% CL:
>= 8 - <= 16
Remarks on result:
other: Effective level was found to be 16 ml/kg bw
Mortality:
THe LD50 was found to be 16mL/kg bw
Clinical signs:
other:
Body weight:
other body weight observations
Remarks:
The surviving animal dosed at 16.0 mg/kg and three of the four animals dosed at 8.0 mg/kg gained weight during the study
Gross pathology:
Gross Pathology observations included congested lungs, liver and spleen, and pale kidneys
Other findings:
Not specified

Any other information on results incl. tables

Table No 1 Mortality Rate





















Dose (ml/kg)



Death  



Days to Death



16



1/2



7



8



0/4



Not applicable


 


Applicant's summary and conclusion

Interpretation of results:
other: Not Classified
Conclusions:
The LD50 for N-(3-(trimethoxysilyl)propyl)ethylenediamine ( CAS number: 1760-24-3) was at least 16.0 ml/kg body weight in male rabbits in an acute dermal toxicity study reported as a summary, but similar to OECD 402 (not GLP, reliability score 4).
Executive summary:

In accordance with guideline 402, an acute dermal toxicity of 1,2-ethanediamine, N-[3-(trimethoxysilyl)propyl] (CAS number: 1760-24-3)was conducted using Rabbit New Zealand species at dose levels 16 and 8 ml/kg bw.

The RA sample was applied to all animals in groups 16ml/kg bw (2 animals) and 8 ml/kg bw (4 animals ) mortality was noted one out of two animals was found to be dead on 7th day of observation at a dose range of 16ml/kg bw, while all the 4 animals were survived at a dose range of 8 ml/kg bw

Necropsy findings, including Gross Pathology observations, included congested lungs, liver and spleen, and pale kidneys

The LD50 value of the test sample was 16.0 ml/kg bw for animals. Hence the test chemical cannot be classified according to CLP criteria.